Enanta Pharmaceuticals reported $77.13M in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbvie ABBV:US $ 9755M 1306M
Acorda Therapeutics ACOR:US $ 116.77M 45.4M
Amgen AMGN:US $ 6112M 154M
Anika Therapeutics ANIK:US $ 94.6M 1.22M
Arrowhead Research ARWR:US $ 372.38M 232.46M
AstraZeneca AZN:LN 15567M 7931M
Biocryst Pharmaceuticals BCRX:US $ 240.36M 31.77M
Biogen BIIB:US $ 1742M 524.5M
Bristol Myers Squibb BMY:US $ 11024M 42M
Clovis Oncology CLVS:US $ 190.92M 49.31M
Enanta Pharmaceuticals ENTA:US $ 77.13M 22.03M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Halozyme Therapeutics HALO:US $ 499.45M 351.75M
Heron Therapeutics HRTX:US $ 59.74M 45.4M
Insmed INSM:US $ 409.75M 123M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Karyopharm Therapeutics KPTI:US $ 88.47M 2.55M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Marinus Pharmaceuticals MRNS:US $ 123.47M 15.04M
Neurocrine Biosciences NBIX:US $ 352.6M 165.5M
Novartis NOVN:VX SF 3801M 5857M
Novavax NVAX:US $ 233.34M 137.23M
Ptc Therapeutics PTCT:US $ 947.08M 800.45M
Sarepta Therapeutics SRPT:US $ 1481.84M 20.81M
Vertex Pharmaceuticals VRTX:US $ 6707.99M 403.66M
Vital Therapies VTL:US $ 114.84M 12.61M
YTE INCY:US $ 1962.39M 449.38M